Article Information
History
- January 19, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Niklas Worm Andersson, MD1,*,
- Emilia Myrup Thiesson, MSc1,
- Ulrike Baum, PhD2,
- Nicklas Pihlström, MSc3,
- Jostein Starrfelt, PhD4,
- Kristýna Faksová, MSc1,
- Eero Poukka, MD2,5,
- Hinta Meijerink, PhD6,
- Rickard Ljung, MD7,8 and
- Anders Hviid, DMSc1,9
- 1Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark
- 2Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00300 Helsinki, Finland
- 3Division of Licensing, Swedish Medical Products Agency, Dag Hammarskjölds väg 42, 751 03 Uppsala, Sweden
- 4Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway
- 5Department of Public Health, Faculty of Medicine, University of Helsinki, Yliopistonkatu 4, 00100 Helsinki, Finland
- 6Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway
- 7Division of Use and Information, Swedish Medical Products Agency, Dag Hammarskjölds väg 42, 751 03 Uppsala, Sweden
- 8Institute of Environmental Medicine, Karolinska Institutet, Nobels väg 13, 171 77 Stockholm, Sweden
- 9Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark
- ↵*Corresponding author: Niklas Worm Andersson, Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark, email: nian{at}ssi.dk, telephone: +45 3268 3159